National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Medical > Global Heart Failure Treatment Market Size, Status and Forecast 2019-2025

Global Heart Failure Treatment Market Size, Status and Forecast 2019-2025

Goods_sn:zhanghuimin-gz3

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

Global Heart Failure Treatment Market Size, Status and Forecast 2019-2025

Hard Copy: 3900 USD
PDF Copy (single user): 3900 USD
Multi User License: 5850 USD
Enterprise wide License: 7800 USD
Pages: 138
Tables and Figures: 155
Published Date: Oct. 2019
Publisher: QYR Medical Care Research Center
Contact: Tel: 1-6262952442; 86-10-82945717; Email: sales@qyresearch.com

Summary

The main treatment for heart failure is etiological treatment.Because heart failure is the ultimate state of the heart, the causes of heart failure are different.Some people may have hyperthyroidism induced heart failure, and the treatment plan is to actively correct hyperthyroidism.Some people because arrhythmia causes tachycardia, cardiomyopathy, control arrhythmia, heart failure will improve naturally.There are still some people who have heart failure caused by ischemic heart disease. They need coronary angiography to actively change the state of heart ischemia, and heart failure can be recovered to a certain extent.There are other diseases, so the etiology of heart failure is important.If heart failure occurs, take active medication.Above all, want to use the therapeutics of heart failure normatively, strong heart, diuresis, dilate blood-vessel is a few treatment means to heart failure acute period, can alleviate improve the symptom of the patient.Chronic treatment of heart failure requires the long-term use of ACEI or ARB, beta blockers and diuretic drugs to reduce the length of hospital stay in patients with heart failure and improve their quality of life, as well as three-chamber pacemaker implantation and heart transplantation.
In 2018, the global Heart Failure Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Heart Failure Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Heart Failure Treatment development in United States, Europe and China.

The key players covered in this study
    Pfizer
    Novartis
    Merck
    Sanofi
    Johnson & Johnson
    AstraZeneca
    GlaxoSmithKline
    Amgen
    Bayer
    BMS
    Cardiorentis
    Cytokinetics
    Ono Pharmaceuticals
    Mylan
    NCPC
    Xinhua Group
    Xudong Haipu Pharmaceutical

Market segment by Type, the product can be split into
    Drug Treatment
    Surgical Treatment

Market segment by Application, split into
    Acute Heart Failure
    Chronic Heart Failure

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Heart Failure Treatment status, future forecast, growth opportunity, key market and key players.
    To present the Heart Failure Treatment development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Heart Failure Treatment are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Heart Failure Treatment Market Size Growth Rate by Type (2014-2025)
        1.4.2 Drug Treatment
        1.4.3 Surgical Treatment
    1.5 Market by Application
        1.5.1 Global Heart Failure Treatment Market Share by Application (2014-2025)
        1.5.2 Acute Heart Failure
        1.5.3 Chronic Heart Failure
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Heart Failure Treatment Market Size
    2.2 Heart Failure Treatment Growth Trends by Regions
        2.2.1 Heart Failure Treatment Market Size by Regions (2014-2025)
        2.2.2 Heart Failure Treatment Market Share by Regions (2014-2019)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Heart Failure Treatment Market Size by Manufacturers
        3.1.1 Global Heart Failure Treatment Revenue by Manufacturers (2014-2019)
        3.1.2 Global Heart Failure Treatment Revenue Market Share by Manufacturers (2014-2019)
        3.1.3 Global Heart Failure Treatment Market Concentration Ratio (CR5 and HHI)
    3.2 Heart Failure Treatment Key Players Head office and Area Served
    3.3 Key Players Heart Failure Treatment Product/Solution/Service
    3.4 Date of Enter into Heart Failure Treatment Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Heart Failure Treatment Market Size by Type (2014-2019)
    4.2 Global Heart Failure Treatment Market Size by Application (2014-2019)

5 United States
    5.1 United States Heart Failure Treatment Market Size (2014-2019)
    5.2 Heart Failure Treatment Key Players in United States
    5.3 United States Heart Failure Treatment Market Size by Type
    5.4 United States Heart Failure Treatment Market Size by Application

6 Europe
    6.1 Europe Heart Failure Treatment Market Size (2014-2019)
    6.2 Heart Failure Treatment Key Players in Europe
    6.3 Europe Heart Failure Treatment Market Size by Type
    6.4 Europe Heart Failure Treatment Market Size by Application

7 China
    7.1 China Heart Failure Treatment Market Size (2014-2019)
    7.2 Heart Failure Treatment Key Players in China
    7.3 China Heart Failure Treatment Market Size by Type
    7.4 China Heart Failure Treatment Market Size by Application

8 Japan
    8.1 Japan Heart Failure Treatment Market Size (2014-2019)
    8.2 Heart Failure Treatment Key Players in Japan
    8.3 Japan Heart Failure Treatment Market Size by Type
    8.4 Japan Heart Failure Treatment Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Heart Failure Treatment Market Size (2014-2019)
    9.2 Heart Failure Treatment Key Players in Southeast Asia
    9.3 Southeast Asia Heart Failure Treatment Market Size by Type
    9.4 Southeast Asia Heart Failure Treatment Market Size by Application

10 India
    10.1 India Heart Failure Treatment Market Size (2014-2019)
    10.2 Heart Failure Treatment Key Players in India
    10.3 India Heart Failure Treatment Market Size by Type
    10.4 India Heart Failure Treatment Market Size by Application

11 Central & South America
    11.1 Central & South America Heart Failure Treatment Market Size (2014-2019)
    11.2 Heart Failure Treatment Key Players in Central & South America
    11.3 Central & South America Heart Failure Treatment Market Size by Type
    11.4 Central & South America Heart Failure Treatment Market Size by Application

12 International Players Profiles
    12.1 Pfizer
        12.1.1 Pfizer Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Heart Failure Treatment Introduction
        12.1.4 Pfizer Revenue in Heart Failure Treatment Business (2014-2019)
        12.1.5 Pfizer Recent Development
    12.2 Novartis
        12.2.1 Novartis Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Heart Failure Treatment Introduction
        12.2.4 Novartis Revenue in Heart Failure Treatment Business (2014-2019)
        12.2.5 Novartis Recent Development
    12.3 Merck
        12.3.1 Merck Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Heart Failure Treatment Introduction
        12.3.4 Merck Revenue in Heart Failure Treatment Business (2014-2019)
        12.3.5 Merck Recent Development
    12.4 Sanofi
        12.4.1 Sanofi Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Heart Failure Treatment Introduction
        12.4.4 Sanofi Revenue in Heart Failure Treatment Business (2014-2019)
        12.4.5 Sanofi Recent Development
    12.5 Johnson & Johnson
        12.5.1 Johnson & Johnson Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Heart Failure Treatment Introduction
        12.5.4 Johnson & Johnson Revenue in Heart Failure Treatment Business (2014-2019)
        12.5.5 Johnson & Johnson Recent Development
    12.6 AstraZeneca
        12.6.1 AstraZeneca Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Heart Failure Treatment Introduction
        12.6.4 AstraZeneca Revenue in Heart Failure Treatment Business (2014-2019)
        12.6.5 AstraZeneca Recent Development
    12.7 GlaxoSmithKline
        12.7.1 GlaxoSmithKline Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Heart Failure Treatment Introduction
        12.7.4 GlaxoSmithKline Revenue in Heart Failure Treatment Business (2014-2019)
        12.7.5 GlaxoSmithKline Recent Development
    12.8 Amgen
        12.8.1 Amgen Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Heart Failure Treatment Introduction
        12.8.4 Amgen Revenue in Heart Failure Treatment Business (2014-2019)
        12.8.5 Amgen Recent Development
    12.9 Bayer
        12.9.1 Bayer Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Heart Failure Treatment Introduction
        12.9.4 Bayer Revenue in Heart Failure Treatment Business (2014-2019)
        12.9.5 Bayer Recent Development
    12.10 BMS
        12.10.1 BMS Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Heart Failure Treatment Introduction
        12.10.4 BMS Revenue in Heart Failure Treatment Business (2014-2019)
        12.10.5 BMS Recent Development
    12.11 Cardiorentis
    12.12 Cytokinetics
    12.13 Ono Pharmaceuticals
    12.14 Mylan
    12.15 NCPC
    12.16 Xinhua Group
    12.17 Xudong Haipu Pharmaceutical

13 Market Forecast 2019-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2019-2025)
    13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details


List of Tables and Figures

    Table Heart Failure Treatment Key Market Segments
    Table Key Players Heart Failure Treatment Covered
    Table Global Heart Failure Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
    Figure Global Heart Failure Treatment Market Size Market Share by Type 2014-2025
    Figure Drug Treatment Figures
    Table Key Players of Drug Treatment
    Figure Surgical Treatment Figures
    Table Key Players of Surgical Treatment
    Table Global Heart Failure Treatment Market Size Growth by Application 2014-2025 (Million US$)
    Figure Acute Heart Failure Case Studies
    Figure Chronic Heart Failure Case Studies
    Figure Heart Failure Treatment Report Years Considered
    Table Global Heart Failure Treatment Market Size 2014-2025 (Million US$)
    Figure Global Heart Failure Treatment Market Size and Growth Rate 2014-2025 (Million US$)
    Table Global Heart Failure Treatment Market Size by Regions 2014-2025 (Million US$)
    Table Global Heart Failure Treatment Market Size by Regions 2014-2019 (Million US$)
    Table Global Heart Failure Treatment Market Share by Regions 2014-2019
    Figure Global Heart Failure Treatment Market Share by Regions 2014-2019
    Figure Global Heart Failure Treatment Market Share by Regions 2019
    Table Market Top Trends
    Table Global Heart Failure Treatment Revenue by Manufacturers (2014-2019) (Million US$)
    Table Global Heart Failure Treatment Market Share by Manufacturers (2014-2019)
    Figure Global Heart Failure Treatment Market Share by Manufacturers in 2019
    Table Global Heart Failure Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Heart Failure Treatment Product/Solution/Service
    Table Date of Enter into Heart Failure Treatment Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Heart Failure Treatment Market Size by Type (2014-2019) (Million US$)
    Table Global Heart Failure Treatment Market Size Share by Type (2014-2019)
    Figure Global Heart Failure Treatment Market Size Market Share by Type (2014-2019)
    Table Global Heart Failure Treatment Market Size by Application (2014-2019) (Million US$)
    Table Global Heart Failure Treatment Market Size Share by Application (2014-2019)
    Figure Global Heart Failure Treatment Market Size Market Share by Application (2014-2019)
    Figure Global Heart Failure Treatment Revenue Market Share by Application in 2018
    Figure United States Heart Failure Treatment Market Size 2014-2019 (Million US$)
    Table United States Key Players Heart Failure Treatment Revenue (2018-2019) (Million US$)
    Table United States Key Players Heart Failure Treatment Market Share (2018-2019)
    Table United States Heart Failure Treatment Market Size by Type (2014-2019) (Million US$)
    Table United States Heart Failure Treatment Market Share by Type (2014-2019)
    Table United States Heart Failure Treatment Market Size by Application (2014-2019) (Million US$)
    Table United States Heart Failure Treatment Market Share by Application (2014-2019)
    Figure Europe Heart Failure Treatment Market Size 2014-2019 (Million US$)
    Table Europe Key Players Heart Failure Treatment Revenue (2014-2019) (Million US$)
    Table Europe Key Players Heart Failure Treatment Market Share (2018-2019)
    Table Europe Heart Failure Treatment Market Size by Type (2014-2019) (Million US$)
    Table Europe Heart Failure Treatment Market Share by Type (2014-2019)
    Table Europe Heart Failure Treatment Market Size by Application (2014-2019) (Million US$)
    Table Europe Heart Failure Treatment Market Share by Application (2014-2019)
    Figure China Heart Failure Treatment Market Size 2014-2019 (Million US$)
    Table China Key Players Heart Failure Treatment Revenue (2018-2019) (Million US$)
    Table China Key Players Heart Failure Treatment Market Share (2018-2019)
    Table China Heart Failure Treatment Market Size by Type (2014-2019) (Million US$)
    Table China Heart Failure Treatment Market Share by Type (2014-2019)
    Table China Heart Failure Treatment Market Size by Application (2014-2019) (Million US$)
    Table China Heart Failure Treatment Market Share by Application (2014-2019)
    Figure Japan Heart Failure Treatment Market Size 2014-2019 (Million US$)
    Table Japan Key Players Heart Failure Treatment Revenue (2014-2019) (Million US$)
    Table Japan Key Players Heart Failure Treatment Market Share (2018-2019)
    Table Japan Heart Failure Treatment Market Size by Type (2014-2019) (Million US$)
    Table Japan Heart Failure Treatment Market Share by Type (2014-2019)
    Table Japan Heart Failure Treatment Market Size by Application (2014-2019) (Million US$)
    Table Japan Heart Failure Treatment Market Share by Application (2014-2019)
    Figure Southeast Asia Heart Failure Treatment Market Size 2014-2019 (Million US$)
    Table Southeast Asia Key Players Heart Failure Treatment Revenue (2018-2019) (Million US$)
    Table Southeast Asia Key Players Heart Failure Treatment Market Share (2018-2019)
    Table Southeast Asia Heart Failure Treatment Market Size by Type (2014-2019) (Million US$)
    Table Southeast Asia Heart Failure Treatment Market Share by Type (2014-2019)
    Table Southeast Asia Heart Failure Treatment Market Size by Application (2014-2019) (Million US$)
    Table Southeast Asia Heart Failure Treatment Market Share by Application (2014-2019)
    Figure India Heart Failure Treatment Market Size 2014-2019 (Million US$)
    Table India Key Players Heart Failure Treatment Revenue (2018-2019) (Million US$)
    Table India Key Players Heart Failure Treatment Market Share (2018-2019)
    Table India Heart Failure Treatment Market Size by Type (2014-2019) (Million US$)
    Table India Heart Failure Treatment Market Share by Type (2014-2019)
    Table India Heart Failure Treatment Market Size by Application (2014-2019) (Million US$)
    Table India Heart Failure Treatment Market Share by Application (2014-2019)
    Figure Central & South America Heart Failure Treatment Market Size 2014-2019 (Million US$)
    Table Central & South America Key Players Heart Failure Treatment Revenue (2018-2019) (Million US$)
    Table Central & South America Key Players Heart Failure Treatment Market Share (2018-2019)
    Table Central & South America Heart Failure Treatment Market Size by Type (2014-2019) (Million US$)
    Table Central & South America Heart Failure Treatment Market Share by Type (2014-2019)
    Table Central & South America Heart Failure Treatment Market Size by Application (2014-2019) (Million US$)
    Table Central & South America Heart Failure Treatment Market Share by Application (2014-2019)
    Table Pfizer Company Details
    Table Pfizer Revenue in Heart Failure Treatment Business (2014-2019) (Million US$)
    Figure Pfizer Revenue Growth Rate in Heart Failure Treatment Business (2014-2019)
    Table Pfizer Recent Development
    Table Novartis Company Details
    Table Novartis Revenue in Heart Failure Treatment Business (2014-2019) (Million US$)
    Figure Novartis Revenue Growth Rate in Heart Failure Treatment Business (2014-2019)
    Table Novartis Recent Development
    Table Merck Company Details
    Table Merck Revenue in Heart Failure Treatment Business (2014-2019) (Million US$)
    Figure Merck Revenue Growth Rate in Heart Failure Treatment Business (2014-2019)
    Table Merck Recent Development
    Table Sanofi Company Details
    Table Sanofi Revenue in Heart Failure Treatment Business (2014-2019) (Million US$)
    Figure Sanofi Revenue Growth Rate in Heart Failure Treatment Business (2014-2019)
    Table Sanofi Recent Development
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Revenue in Heart Failure Treatment Business (2014-2019) (Million US$)
    Figure Johnson & Johnson Revenue Growth Rate in Heart Failure Treatment Business (2014-2019)
    Table Johnson & Johnson Recent Development
    Table AstraZeneca Company Details
    Table AstraZeneca Revenue in Heart Failure Treatment Business (2014-2019) (Million US$)
    Figure AstraZeneca Revenue Growth Rate in Heart Failure Treatment Business (2014-2019)
    Table AstraZeneca Recent Development
    Table GlaxoSmithKline Company Details
    Table GlaxoSmithKline Revenue in Heart Failure Treatment Business (2014-2019) (Million US$)
    Figure GlaxoSmithKline Revenue Growth Rate in Heart Failure Treatment Business (2014-2019)
    Table GlaxoSmithKline Recent Development
    Table Amgen Company Details
    Table Amgen Revenue in Heart Failure Treatment Business (2014-2019) (Million US$)
    Figure Amgen Revenue Growth Rate in Heart Failure Treatment Business (2014-2019)
    Table Amgen Recent Development
    Table Bayer Company Details
    Table Bayer Revenue in Heart Failure Treatment Business (2014-2019) (Million US$)
    Figure Bayer Revenue Growth Rate in Heart Failure Treatment Business (2014-2019)
    Table Bayer Recent Development
    Table BMS Company Details
    Table BMS Revenue in Heart Failure Treatment Business (2014-2019) (Million US$)
    Figure BMS Revenue Growth Rate in Heart Failure Treatment Business (2014-2019)
    Table BMS Recent Development
    Table Cardiorentis Company Details
    Table Cytokinetics Company Details
    Table Ono Pharmaceuticals Company Details
    Table Mylan Company Details
    Table NCPC Company Details
    Table Xinhua Group Company Details
    Table Xudong Haipu Pharmaceutical Company Details
    Table Global Heart Failure Treatment Market Size by Regions (Million US$) 2019-2025
    Figure Global Heart Failure Treatment Market Size Share by Regions (2019-2025)
    Figure Global Heart Failure Treatment Market Size Share by Regions in 2025
    Figure United States Heart Failure Treatment Market Size Forecast (2019-2025)(Million USD)
    Figure Europe Heart Failure Treatment Market Size Forecast (2019-2025)(Million USD)
    Figure China Heart Failure Treatment Market Size Forecast (2019-2025)(Million USD)
    Figure Japan Heart Failure Treatment Market Size Forecast (2019-2025)(Million USD)
    Figure Southeast Asia Heart Failure Treatment Market Size Forecast (2019-2025)(Million USD)
    Figure India Heart Failure Treatment Market Size Forecast (2019-2025)(Million USD)
    Figure Central & South America Heart Failure Treatment Market Size Forecast (2019-2025)(Million USD)
    Table Global Heart Failure Treatment Market Size by Product (2019-2025) (Million US$)
    Figure Global Heart Failure Treatment Market Size by Product (2019-2025)
    Figure Global Heart Failure Treatment Market Size by Product in 2025
    Table Global Heart Failure Treatment Market Size by Application (2019-2025) (Million US$)
    Figure Global Heart Failure Treatment Market Size by Application (2019-2025)
    Figure Global Heart Failure Treatment Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Request sample If you need any reports sample, just let us know.